No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts.
Wright EJ, Grund B, Robertson KR, Cysique L, Brew BJ, Collins GL, Poehlman-Roediger M, Vjecha MJ, Penalva de Oliveira AC, Standridge B, Carey C, Avihingsanon A, Florence E, Lundgren JD, Arenas-Pinto A, Mueller NJ, Winston A, Nsubuga MS, Lal L, Price RW; INSIGHT START Neurology Substudy Group.
Wright EJ, et al. Among authors: lundgren jd.
AIDS. 2018 May 15;32(8):985-997. doi: 10.1097/QAD.0000000000001778.
AIDS. 2018.
PMID: 29424786
Free PMC article.
Clinical Trial.